Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 8, 2023. (Total: 217765Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 19 (of 19 Records)

Query Trace: Splenomegaly and CALR[original query]
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia.
Hematology reports 2022 Aug 14 (3): 265-269.
Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62.
An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof
A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia.
International journal of hematology 2015 Feb 101 (2): 165-72.
Yang Yining, Wang Xiaorui, Wang Chun, Qin Youw
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Jul .
Pei Yu-Qing, Wu Yue, Wang Fei, Cui W
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
British journal of haematology 2016 Jun .
Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire
Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
Annals of hematology 2016 Dec .
Lekovic Danijela, Gotic Mirjana, Skoda Radek, Beleslin-Cokic Bojana, Milic Natasa, Mitrovic-Ajtic Olivera, Nienhold Ronny, Sefer Dijana, Suboticki Tijana, Buac Marijana, Markovic Dragana, Diklic Milos, Cokic Vladan
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Sep .
Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq
Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.
Leukemia research 2017 Jun 60 18-23.
Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor
The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.
American journal of hematology 2017 Feb .
Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal
Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2 mutations and laboratory findings: a meta-analysis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb .
Saki N, Shirzad R, Rahim F, Saki Malehi
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.
Oncotarget 2017 12 8 (60): 101735-101744.
Rumi Elisa, Boveri Emanuela, Bellini Marta, Pietra Daniela, Ferretti Virginia V, Sant'Antonio Emanuela, Cavalloni Chiara, Casetti Ilaria C, Roncoroni Elisa, Ciboddo Michele, Benvenuti Pietro, Landini Benedetta, Fugazza Elena, Troletti Daniela, Astori Cesare, Cazzola Mario,
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.
Neoplasma 2018 65 (2): 296-303.
Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
International journal of hematology 2018 Feb .
Misawa Kyohei, Yasuda Hajime, Araki Marito, Ochiai Tomonori, Morishita Soji, Shirane Shuichi, Edahiro Yoko, Gotoh Akihiko, Ohsaka Akimichi, Komatsu Nor
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.
Leukemia research 2018 Jan 65 42-48.
Gángó Ambrus, Mózes Réka, Boha Zsófia, Kajtár Béla, Timár Botond, Király Péter Attila, Kiss Richárd, Fésüs Viktória, Nagy Noémi, Demeter Judit, Körösmezey Gábor, Borbényi Zita, Marton Imelda, Sz?ke Anita, Masszi Tamás, Farkas Péter, Várkonyi Judit, Plander Márk, Pósfai Éva, Egyed Miklós, Pál Katalin, Radványi Gáspár, Hamed Aryan, Csomor Judit, Matolcsy András, Alpár Donát, Bödör Csa
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.
Blood cells, molecules & diseases 2019 1 75 35-40.
Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
American journal of hematology 2021 Aug .
Loscocco Giuseppe G, Guglielmelli Paola, Gangat Naseema, Rossi Elena, Mannarelli Carmela, Betti Silvia, Maccari Chiara, Ramundo Francesco, Jadoon Yamna, Gesullo Francesca, Ceglie Sara, Paoli Chiara, Pardanani Animesh, De Stefano Valerio, Tefferi Ayalew, Vannucchi Alessandro
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms.
Haematologica 2020 11 .
Schino Mattia, Fiorentino Vincenzo, Rossi Elena, Betti Silvia, Di Cecca Monica, Ranucci Valentina, Chiusolo Patrizia, Martini Maurizio, De Stefano Valerio, Larocca Luigi Mar
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL.
Technology in cancer research & treatment 2023 2 22 15330338231154092.
Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience.
Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209.
Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar
TOP